Defined Wealth Management’s Elevance Health ELV Stock Holding History

Defined Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,331	Closed	-$518K	–	109
2025 Q2	$518K	Sell	1,331 -21	-2%	-$8.45K	0.32%	72
2025 Q1	$588K	Buy	1,352 +12	+0.9%	+$4.82K	0.4%	55
2024 Q4	$494K	Sell	1,340 -429	-24%	-$180K	0.33%	66
2024 Q3	$920K	Buy	1,769 +9	+0.5%	+$4.81K	0.6%	44
2024 Q2	$954K	Buy	1,760 +3	+0.2%	+$1.59K	0.66%	40
2024 Q1	$911K	Buy	1,757 +1	+0.1%	+$497	0.65%	43
2023 Q4	$828K	Buy	1,756 +3	+0.2%	+$1.39K	0.63%	43
2023 Q3	$763K	Buy	1,753 +7	+0.4%	+$3.17K	0.65%	43
2023 Q2	$776K	Buy	1,746 +1	+0.1%	+$461	0.65%	45
2023 Q1	$802K	Hold	1,745	–	–	0.75%	38
2022 Q4	$895K	Hold	1,745	–	–	0.84%	32
2022 Q3	$793K	Hold	1,745	–	–	0.86%	32
2022 Q2	$842K	Hold	1,745	–	–	0.86%	29
2022 Q1	$857K	Hold	1,745	–	–	0.75%	30
2021 Q4	$809K	Hold	1,745	–	–	0.66%	36
2021 Q3	$651K	Hold	1,745	–	–	0.58%	37
2021 Q2	$666K	Hold	1,745	–	–	0.59%	34
2021 Q1	$626K	Hold	1,745	–	–	0.59%	33
2020 Q4	$560K	Buy	+1,745	New	+$536K	0.55%	38

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Defined Wealth Management's ELV Position: Q3 2025 in Review

Defined Wealth Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,331 shares — an estimated $518K sold.

Defined Wealth Management first reported a position in ELV in Q4 2020 and held it in 19 quarters. The position peaked at $954K in Q2 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Defined Wealth Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Defined Wealth Management sold 1,331 Elevance Health shares in Q3 2025, an estimated $518K.
Defined Wealth Management first reported a position in Elevance Health in Q4 2020 and held it in 19 quarters.
Defined Wealth Management's Elevance Health position peaked at $954K in Q2 2024.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Defined Wealth Management's 13F filing for Q3 2025, filed 7 Oct 2025.